dQ&A Market Metrics
What’s Your Number?
Whatever question brought you here, it probably comes down to a number. How big is the market? How many patients are on this therapy? What share use this device?
Market Metrics was built to answer exactly that — quickly, reliably, and without commissioning custom research.
The Authoritative Map of the U.S. Diabetes Market
dQ&A Market Metrics is a detailed, continuously maintained map of the U.S. diabetes market. It provides population and percentage estimates across diabetes segments, therapies, devices, brands, and clinical measures — telling you exactly how many patients are in each segment, and what share they represent.
It is a weighted population model, grounded in large-scale primary data from dQ&A's proprietary patient panels and prescriber research. Every estimate is thoroughly researched, rigorously constructed, and defensible.
Market Metrics is delivered via a flexible self-service web portal, giving you direct access to current market size and market share data across whichever segment, therapy, or device matters to you.
What You Can Measure
The Full Scope of Market Metrics
Across these populations: All PWDs · All Type 1 · All Type 2 · T1 Adults · T1 Kids · T2 No Insulin · T2 Basal Only · T2 Intensive Insulin · T2 GLP-1 User · T2 No GLP-1
*Each of the over 800 estimates are available as both an absolute patient population figure and a percentage share of the relevant segment.
Why Believe These Estimates?
Market Metrics starts with core benchmarks for the U.S. diagnosed diabetes population drawn from CDC, NHANES, and NHIS, and corroborated with dQ&A's own research among people with diabetes and healthcare professionals.
We apply iterative proportional fitting to weight our patient panel — approximately n=6,000 people with diabetes surveyed every quarter — so it accurately represents the wider U.S. diabetes population. The panel is purposely deep and wide: overweighted in areas of clinical interest such as Type 1 diabetes, CGM users, and AID users, so we can create a detailed weighting with good statistics and be confident of our numbers.
Confidence intervals and model error are assessed for every estimate. If we are not confident in a number, we don't publish it.
Note also that the underlying data comes from real people. It is not synthetic.
More information on our methodology is available from dQ&A – please contact us for details.
Need Help Finding Your Number?
Our team knows this market. If you're not sure which estimates are relevant to your question, or you'd like to see Market Metrics in action, we would be happy to help.
Talk to us about your market.
Do You Have Questions
About Diabetes Research?
dQ&A’s diabetes data services can deliver immediate answers to a broad range of diabetes questions. Just ask us! If you are interested in learning about how we can help your business, please get in touch. We would be delighted to hear from you.
